http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. When a research team in China evaluated the efficacy and safety of using mesenchymal stem cells (MSCs) expanded from the bone marrow of non-self-donors to treat patients experiencing poor graft function (PGF) after receiving transplants of non-self-donated blood stem cells (allo-HSCT), they found that the mesenchymal stem cells were both safe and effective for treating primary and secondary PGF. http://medicalxpress.com/news/2013-03-third-party-blood-stem-cell-transplantation.html Medical research Mon, 18 Mar 2013 13:43:50 EST news282833021 Researchers from Italy have found that the antioxidant, N-acetylcysteine (NAC), when injected prior to harvesting of the liver, significantly improves graft survival following transplantation. Results published in the February issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases (AASLD), suggest that the NAC effect on early graft function and survival is higher when suboptimal organs are used. http://medicalxpress.com/news/2013-02-antioxidant-donated-liver-survival-percent.html Other Mon, 25 Feb 2013 12:39:18 EST news281018346 In a research review article published in the American Journal of Nephrology, Saint Louis University investigators examined data from multiple studies to better understand how obesity, an epidemic in the U.S., impacts kidney transplant patients. The authors report that, even as some connections between weight and health outcomes are unknown or contradictory, there is evidence that obese kidney transplant patients don't do as well after surgery, experiencing more adverse outcomes, including wound infections, delayed graft function, graft failure, cardiac disease and increased costs. http://medicalxpress.com/news/2013-01-patients-heavy-kidney.html Diseases, Conditions, Syndromes Mon, 14 Jan 2013 12:44:20 EST news277389754 A study published in the current issue of Cell Transplantation (21:8), now freely available on-line, reports that a team of researchers in South Korea have successfully engineered islet cell clusters (ICCs) that will improve pancreatic islet transplantation and offer promise for curing diabetes mellitus. http://medicalxpress.com/news/2012-11-islet-cell-advancement-impact-transplantation.html Medical research Tue, 27 Nov 2012 11:54:58 EST news273239689